New Forecasts: Here's What Analysts Think The Future Holds For C4 Therapeutics, Inc. (NASDAQ:CCCC)

By Yahoo! Finance | Aug 4, 2024 at 11:26 AM EST

Analysts upgraded C4 Therapeutics' revenue forecasts, predicting a 3.1% decline in sales in 2024. Despite reduced losses and improved revenue outlook, the consensus price target fell 14%. The company is moving towards profitability, but faces challenges compared to industry peers.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.